Shaum Sridharan
Otolaryngology · Washington, DCNPI 1114192184
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,301 of the $8,379 with a category attached, or 75.2%. Medical Device Business Services, Inc. accounts for 81.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $6,459 and has fallen 95.1% since, to $319 in 2025.
Across 27 payments — averaging $310.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$7K
- Integra Lifesciences Corporation$411
- Axogen$343
- Baxter Healthcare$301
- Johnson & Johnson$257
- Stryker$159
- plus $105 from 1 others
What the payments were for
- Consulting fees$6,30175%
- Travel & lodging$911%
- Food & beverage$1,98824%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 11 | $6,802 |
| Integra Lifesciences Corporation | 4 | $411 |
| Axogen | 4 | $343 |
| Baxter Healthcare | 4 | $301 |
| Johnson & Johnson | 2 | $257 |
| Stryker | 1 | $159 |
| Checkpoint Surgical, Inc | 1 | $105 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRUMATCH$6,534
- MATRIXMANDIBLE$6,444
- INTEGRA$686
- PRIMATRIX$366
- INTEGRA DERMAL REGENERATION TEMPLATE$229
- NA$159
- MATRIXMIDFACE$143
- BILAYER WOUND MATRIX (BWM)$137
- INTEGRA WOUND MATRIX (IWM)$137
- IDRT$137
- FLOWABLE$137
- AVANCE NERVE GRAFT$106
- AxoGuard Nerve Connector$106
- AxoGuard Nerve Protector$106
- AXOGUARD HA+ NERVE PROTECTOR$106
- AxoGuard Nerve Cap$106
- Checkpoint Stimulators$105
How this compares
$8,379 in reported general payments places this provider in the 85th percentile of 41 otolaryngology providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pentoxifylline | 11 | $249 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $215 |
| Famotidine | 19 | $163 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Washington
- Michael HoaWashington$57K
- Manish KhannaWashington$24K
- Sarah RapoportWashington$11K
- Hung KimWashington$11K
- Punam ThakkarWashington$9K
- Stanley ChiaWashington$4K
- William GaoWashington$3K
- Stephen WallWashington$3K
- Adedoyin KalejaiyeWashington$3K
- Mark RussoWashington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.